Stay updated with breaking news from Factor Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho
Lineage Cell Therapeutics, Inc. ; class='js-l-obf link link--blue'
NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued
Factor Bioscience to Deliver Six Digital Presentations at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting -The presentations will reveal advances in mRNA, circleRNA, gene editing, cell reprogramming, and iPS cell-derived NK-cell technologies. - Factor's participation in this year's ASGCT Annual Meeting marks the company's ten-year anniversary and represents the most comprehensive presentation of the company's data to date. News provided by Share this article Share this article CAMBRIDGE, Mass., May 11, 2021 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based bio...